Please use this identifier to cite or link to this item:
Title: Multitarget compounds bearing tacrine- and donepezil-like structural and functional motifs for the potential treatment of Alzheimer's disease
Authors: Ismaili, Lhassane
Refouvelet, Bernard
Benchekroun, Mohamed
Brogi, Simone
Brindisi, Margherita 
Gemma, Sandra 
Campiani, Giuseppe 
Filipic, Slavica
Agbaba, Danica
Esteban, Gerard
Unzeta, Mercedes
Nikolic, Katarina
Butini, Stefania 
Marco-Contelles, José
Keywords: Acetylcholinesterase; Alzheimer's disease; Beta secretase; Butyrylcholinesterase; Cholinesterases; Histamine receptor; Monoamine oxidases; Multi-target-directed ligand; Nitric oxide; Reactive oxygen species; Serotonin receptors; β-Amyloid
Issue Date: 2016
Project: None 
Alzheimer's disease is a multifactorial and fatal neurodegenerative disorder characterized by decline of cholinergic function, deregulation of other neurotransmitter systems, β-amyloid fibril deposition, and β-amyloid oligomers formation. Based on the involvement of a relevant number of biological systems in Alzheimer's disease progression, multitarget compounds may enable therapeutic efficacy. Accordingly, compounds possessing, besides anticholinergic activity and β-amyloid aggregation inhibition properties, metal chelating and/or nitric oxide releasing properties with additional antioxidant capacity were developed. Other targets relevant to Alzheimer's disease have also been considered in the last years for producing multitarget compounds such as β-secretase, monoamino oxidases, serotonin receptors and sigma 1 receptors. The purpose of this review will be to highlight recent reports on the development of multitarget compounds for Alzheimer's disease published within the last years focusing on multifunctional ligands characterized by tacrine-like and donepezil-like structures.
ISSN: 0301-0082
DOI: 10.1016/j.pneurobio.2015.12.003
Appears in Collections:Publications

Show full item record

Google ScholarTM



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.